结果：去纤酶组显著改善神经功能缺失程度，提高日常生活能力，降低血纤维蛋白原水平；
Results: The neurological function of the patients treated with defibrase was significantly improved, the scores of daily living abilities increased, and the level of fibrinogen in blood decreased.
结论：高血压、血纤溶系统活性升高、高水平纤维蛋白原、高同型半胱氨酸血症是脑梗死再发的重要危险因素。
Conclusion Hypertension, increased plasma PAI-1 activity, fibrinogen level and plasma Hcy level are the important risk factors in the recurrent cerebral infarction.
结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
前言：目的：探讨脑梗塞患者血高甘油三酯与纤溶系统异常的危险因素。
Objective: to study the risk factor of Triglyceride and Plasminogen Activity on abnormal in patients with Cerbral Infarction.
同时观察到“镇眩汤”可以降低血黏度，促进纤溶活性，改善脂质代谢。
It was also noted that the decoction could lower blood viscosity, promote fibrinolytic activity and improve lipid metabolism.
目的：研究益肾活血方对家兔血瘀模型纤溶指标与血液流变状态的影响，并探讨其机制。
Objective: to evaluate the effect of decoction for invigorating the kidney and improving blood circulation to thrombosis and pathology on rabbit blood stasis model.
继发性纤溶亢进表现为般血醉凝固时间延长。
The sequential filament dissolves the hyperfunction performance to be drunk the setting time extension for the blood.
降纤酶有明显降低血黏度、纤维蛋白原含量、红细胞聚集性、血小板聚集作用。
Defibrase can effectively reduce blood viscosity, content of fibrinogen, hemocyte aggregation and platelet aggregation.
结论：降纤酶治疗急性脑梗死疗效确切，能显著降低纤维蛋白原，改善全血黏度，降低致残率，不良反应少。
Conclusion: Defibrase can significantly decrease fibrinogen, improve whole blood viscosity, and decrease disability rate. With little side effect, it is effective on acute cerebral infarction.
目的：观察脑血宝制剂对血液凝固与纤溶活性的影响。
Objective:To observe the thrombolytic effect of Naoxuebao in vitro and in vivo.
目的：观察脑血宝制剂对血液凝固与纤溶活性的影响。
Objective:To observe the thrombolytic effect of Naoxuebao in vitro and in vivo.
应用推荐